"10.1371_journal.pone.0128271","plos one","2015-06-05T00:00:00Z","Maeve O’Leary-Barrett; Robert O Pihl; Eric Artiges; Tobias Banaschewski; Arun L W Bokde; Christian Büchel; Herta Flor; Vincent Frouin; Hugh Garavan; Andreas Heinz; Bernd Ittermann; Karl Mann; Marie-Laure Paillère-Martinot; Frauke Nees; Tomas Paus; Zdenka Pausova; Luise Poustka; Marcella Rietschel; Trevor W Robbins; Michael N Smolka; Andreas Ströhle; Gunter Schumann; Patricia J Conrod; IMAGEN Consortium","Department of Psychology McGill University, Montreal, Quebec, Canada; Institut National de la Santé et de la Recherche Médicale, INSERM CEA Unit 1000 “Imaging & Psychiatry”, University Paris Sud, Orsay, Paris, France; AP-HP Department of Adolescent Psychopathology and Medicine, Maison de Solenn, University Paris Descartes, Paris, France; Department of Child and Adolescent Psychiatry and Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Trinity College Institute of Neuroscience and Discipline of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Central Institute of Mental Health, Mannheim, Germany; Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris, France; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont, United States of America; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité –Universitätsmedizin Berlin, Berlin, Germany; Physikalisch-Technische Bundesanstalt (PTB), Braunschweig und Berlin, Berlin, Germany; Rotman Research Institute, University of Toronto, Toronto, Ontario, Canada; School of Psychology, University of Nottingham, Nottingham, United Kingdom; Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada; The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; Behavioural and Clinical Neurosciences Institute, Department of Experimental Psychology, University of Cambridge, Cambridge, United Kingdom; Department of Psychiatry and Psychotherapy, and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité –Universitätsmedizin Berlin, Berlin, Germany; MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, King’s College London, London, United Kingdom; Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, King’s College London, United Kingdom; Department of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montreal, Quebec, Canada","Conceived and designed the experiments: PC GS CB HF HG M-LPM TP MR TR. Performed the experiments: PC GS EA TB AB CB HF VF HG AH BI KM M-LPM FN TP ZP LP MR TR MS AS. Analyzed the data: MO-B PC. Contributed reagents/materials/analysis tools: VF FN. Wrote the paper: MO-B PC RP.","Trevor W. Robbins consults for Cambridge Cognition, E Lilly, GlaxoSmithKline, Merck Sharpe, Lundbeck and Dohme, Teva and Shire Pharmaceuticals, and has received recent research grants from Lilly, GSK and Lundbeck. Tobias Banaschewski served in an advisory or consultancy role for Bristol Myers-Squibb, Develco Pharma, Lilly, Medice, Novartis, Shire and Viforpharma. He received conference attendance support and speaker's fees from Lilly, Janssen McNeil, Medice, Novartis and Shire. He is and has been involved in clinical trials conducted by Lilly and Shire. The present work is unrelated to the Tobias Banaschewski's grants and relationships. This does not alter the authors' adherence to PLOS ONE’s policies on sharing data and materials.","2015","06","Maeve O’Leary-Barrett","MOLB",24,TRUE,9,21,2,3,FALSE,FALSE,TRUE,2,"1;24",TRUE
